Purchase this article with an account.
Sophie X. Deng, Aurelie Dos Santos, Serina Gee; Therapeutic Potential of Extracellular Vesicles for the Treatment of Corneal Injuries and Scars. Trans. Vis. Sci. Tech. 2020;9(12):1. doi: https://doi.org/10.1167/tvst.9.12.1.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Infection, trauma, and chemical exposure of the ocular surface can severely damage the cornea, resulting in visually significant stromal scars. Current medical treatments are ineffective in mitigating corneal scarring, and corneal transplantation is the only therapy able to restore vision in these eyes. However, because of a severe shortage of corneal tissues, risks of blinding complications associated with corneal transplants, and a higher rate of graft failure in these eyes, an effective and deliverable alternative therapy for the prevention and treatment of corneal scarring remains a significant unmet medical need globally. In recent years, the therapeutic potential of extracellular vesicles (EVs) secreted by cells to mediate cell-cell communication has been a topic of increasing interest. EVs derived from mesenchymal stem cells, in particular human corneal stromal stem cells, have antifibrotic, anti-inflammatory, and regenerative effects in injured corneas. The exact mechanism of action of these functional EVs are largely unknown. Therapeutic development of EVs is at an early stage and warrants further preclinical studies.
This PDF is available to Subscribers Only